Left Atrial Appendage Closure Devices Market Analysis | 2023-2028

Left Atrial Appendage Closure Devices Market Analysis | 2023-2028

Left Atrial Appendage Closure Devices Market Analysis | 2023-2028
Report code - SRHL188 Delivery - 2 Weeks
Left Atrial Appendage Closure Devices Market Size, Share, Trends, Dynamics, Forecast, & See more...

Market Insights

The left atrial appendage closure devices market was estimated at USD 1.25 billion in 2022 and is likely to grow at a CAGR of 20.27% during 2023-2028 to reach USD 3.8 billion in 2028.

Left-Atrial-Appendage-Closure-Devices-Market-Insights

Want to know more about the market scope? Register Here

Market Dynamics

Introduction

Left atrial appendage closure is a technique that assists in lowering the risk of stroke. It (LAA) is a small-sized, ear-shaped sac sited in the muscle wall of the left atrium. Left atrial appendage closure devices are used to reduce the possibility of blood clots, thus preventing stroke. They are implantable cardiac devices that are placed in the left atrial appendage for the prevention of stroke in patients.

Market Drivers

The major factors driving the growth of the left atrial appendage closure devices market are:

  • The growing aging population.
  • Increasing occurrence of atrial fibrillation.
  • Increasing government initiatives.
  • The technological advancements taking place in the market.

Left-Atrial-Appendage-Closure-Devices-Market-Dynamics

Want to have a closer look at this market report? Register Here

Key Players

Some of the major left atrial appendage closure device manufacturers are:

  • Abbott Laboratories
  • Aegis Medical Group
  • AtriCure Inc.
  • Boston Scientific Corporation
  • Coherex Medical Inc.
  • Dune Medical Devices
  • Johnson & Johnson Services, Inc.
  • Lifetech Scientific
  • Cardia, Inc.
  • Occlutech International AB
  • St. Jude Medical, Inc.

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segments Analysis

Segmentations

List of Sub-Segments

Segments with High Growth Opportunity

Product Type Analysis

Endocardial LAA Closure Devices, Epicardial LAA Closure Devices

The epicardial left atrial appendage closure device segment is estimated to grow at a higher CAGR during the forecast period.

Procedure Type Analysis

Percutaneous, Surgical

The surgical procedure segment is expected to witness impressive growth during the forecast period.

Regional Analysis

North America, Europe, Asia-Pacific, and Rest of the World

North America is estimated to be the fastest-growing region for the left atrial appendage closure devices market.

By Product Type

Based on the product type, the market is segmented as endocardial LAA devices and epicardial LAA devices. The epicardial left atrial appendage closure device segment is estimated to grow at a higher CAGR during the forecast period, driven by its ability to nullify the need for implanting a permanent device. Also, these devices do not require anticoagulation post-procedure, further accelerating the market growth.

By Procedure Type

Based on the procedure type, the market is segmented as percutaneous and surgical. The surgical procedure segment is expected to witness impressive growth during the forecast period, owing to the availability of different surgical approaches to LAA occlusion such as suture exclusion, stapler excision, epicardial exclusion clips, and suture loops.

Regional Insights

In terms of regions, North America is estimated to be the fastest-growing region for the left atrial appendage closure devices market, driven by the increasing number of patients suffering from atrial fibrillation coupled with other arrhythmias in Canada. Europe and Asia-Pacific are also expected to offer promising growth opportunities during the forecast period.

Left-Atrial-Appendage-Closure-Devices-Market-Regional-Insights

Know the high-growth countries in this report. Click Here

Research Methodology

  • This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects left atrial appendage closure devices market realities and future market possibilities for the forecast period.
  • The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
  • The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
  • This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
  • More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
  • We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
  • Market trend and forecast analysis.
  • Market segment trend and forecast.
  • Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
  • COVID-19 impact and its recovery curve
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.
  • Strategic growth opportunities for the existing and new players.
  • Key success factors.

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The left atrial appendage closure devices market is segmented into the following categories:

By Product Type

  • Endocardial LAA Devices
  • Epicardial LAA Devices

By Procedure Type

  • Percutaneous
  • Surgical

By End-Use Type

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Region

  • North America (Country Analysis: the USA, Canada, and Mexico)
  • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
  • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
  • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Left-Atrial-Appendage-Closure-Devices-Market-Segmentation

Know more about various segments of this report. Register Here

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to 3 players)
  • SWOT analysis of key players (up to 3 players)

Market Segmentation

  • Current market segmentation of any one of the product types by end-use type.

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Left atrial appendage closure is a technique that assists in lowering the risk of stroke. It (LAA) is a small-sized, ear-shaped sac sited in the muscle wall of the left atrium. Left atrial appendage closure devices are used to reduce the possibility of blood clots, thus preventing stroke. They are implantable cardiac devices that are placed in the left atrial appendage for the prevention of stroke in patients.

The left atrial appendage closure devices market was estimated at USD 1.25 billion in 2022.

The left atrial appendage closure devices market is likely to reach USD 3.8 billion in 2028.

The left atrial appendage closure devices market is likely to grow at a CAGR of 20.27% during 2023-2028.

Abbott Laboratories, Aegis Medical Group, AtriCure Inc., Boston Scientific Corporation, Coherex Medical Inc., Dune Medical Devices, Johnson & Johnson Services, Inc., Lifetech Scientific, Cardia, Inc., Occlutech International AB, and St. Jude Medical, Inc. are among the key players in the market.

North America is expected to be the fastest-growing market.

The epicardial left atrial appendage closure device segment is expected to grow at a higher CAGR in the market.